{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:21:34Z","timestamp":1790752894287,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["22322"],"award-info":[{"award-number":["22322"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.exer.2022.108961","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T23:12:13Z","timestamp":1643411533000},"page":"108961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["RPE based gene and cell therapy for inherited retinal diseases: A review"],"prefix":"10.1016","volume":"217","author":[{"given":"Fatemeh","family":"Sanie-Jahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7412-1900","authenticated-orcid":false,"given":"M. Hossein","family":"Nowroozzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1101\/gr.144105.112","article-title":"Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes","volume":"23","author":"Abu-Safieh","year":"2013","journal-title":"Genome Res."},{"issue":"5","key":"10.1016\/j.exer.2022.108961_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/5.5.591","article-title":"Gene transfer into the mouse retina mediated by an adeno-associated viral vector","volume":"5","author":"Ali","year":"1996","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.exer.2022.108961_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.stemcr.2014.03.011","article-title":"Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice","volume":"2","author":"Assawachananont","year":"2014","journal-title":"Stem Cell. Rep."},{"issue":"5","key":"10.1016\/j.exer.2022.108961_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.hoc.2017.06.007","article-title":"Nonintegrating gene therapy vectors","volume":"31","author":"Athanasopoulos","year":"2017","journal-title":"Hematol.\/Oncol. Clin."},{"issue":"26","key":"10.1016\/j.exer.2022.108961_bib5","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"20","key":"10.1016\/j.exer.2022.108961_bib6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.exer.2022.108961_bib7","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.exer.2022.108961_bib8","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1371\/journal.pmed.0020333","article-title":"Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis","volume":"2","author":"Batten","year":"2005","journal-title":"PLoS Med."},{"issue":"10045","key":"10.1016\/j.exer.2022.108961_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.exer.2022.108961_bib10","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.3390\/ijms21124197","article-title":"Recombinant adeno-associated viral vectors (rAAV)-vector elements in ocular gene therapy clinical trials and transgene expression and bioactivity assays","volume":"21","author":"Buck","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.exer.2022.108961_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005290","article-title":"A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles","volume":"4","author":"Cai","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0092-8674(80)90358-X","article-title":"High efficiency transformation by direct microinjection of DNA into cultured mammalian cells","volume":"22","author":"Capecchi","year":"1980","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.exer.2022.108961_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008152","article-title":"Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat","volume":"4","author":"Carr","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2022.108961_bib14","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/mtm.2015.22","article-title":"AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice","volume":"2","author":"Choi","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"9","key":"10.1016\/j.exer.2022.108961_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/hum.2009.086","article-title":"Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year","volume":"20","author":"Cideciyan","year":"2009","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmed.2008.11.003","article-title":"Ocular gene therapy: current progress and future prospects","volume":"15","author":"Colella","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.exer.2022.108961_bib17","first-page":"456","article-title":"Non-viral ocular gene therapy: assessment and future directions","volume":"10","author":"Conley","year":"2008","journal-title":"Curr. Opin. Mol. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13816810.2011.620056","article-title":"Choroideremia: a review of general findings and pathogenesis","volume":"33","author":"Coussa","year":"2012","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.exer.2022.108961_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2018.06.011","article-title":"Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience","volume":"193","author":"Dimopoulos","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2022.108961_bib20","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1167\/iovs.12-11239","article-title":"Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer","volume":"54","author":"Diniz","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"17","key":"10.1016\/j.exer.2022.108961_bib21","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","article-title":"Quantitative analysis of the packaging capacity of recombinant adeno-associated virus","volume":"7","author":"Dong","year":"1996","journal-title":"Hum. Gene Ther."},{"issue":"7","key":"10.1016\/j.exer.2022.108961_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1088\/0031-9155\/49\/7\/010","article-title":"Three-dimensional cellular-level imaging using full-field optical coherence tomography","volume":"49","author":"Dubois","year":"2004","journal-title":"Phys. Med. Biol."},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1167\/iovs.13-13834","article-title":"Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy","volume":"55","author":"Duncker","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"20","key":"10.1016\/j.exer.2022.108961_bib24","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia","volume":"374","author":"Edwards","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/bjo.2009.176305","article-title":"Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study","volume":"95","author":"Falkner-Radler","year":"2011","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib26","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pone.0000038","article-title":"Efficient non-viral ocular gene transfer with compacted DNA nanoparticles","volume":"1","author":"Farjo","year":"2006","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.exer.2022.108961_bib27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/hum.2019.017","article-title":"Development of a gene therapy vector for RDH12-associated retinal dystrophy","volume":"30","author":"Feathers","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"23","key":"10.1016\/j.exer.2022.108961_bib28","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.84.23.8463","article-title":"Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading","volume":"84","author":"Fechheimer","year":"1987","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/IAE.0000000000002360","article-title":"Changes in retinal sensitivity after gene therapy in choroideremia","volume":"40","author":"Fischer","year":"2020","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","article-title":"Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial","volume":"135","author":"Ghazi","year":"2016","journal-title":"Hum. Genet."},{"issue":"7092","key":"10.1016\/j.exer.2022.108961_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"issue":"47","key":"10.1016\/j.exer.2022.108961_bib32","doi-asserted-by":"crossref","first-page":"45537","DOI":"10.1074\/jbc.M208882200","article-title":"Dual-substrate specificity short chain retinol dehydrogenases from the vertebrate retina","volume":"277","author":"Haeseleer","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1152\/physrev.00022.2007","article-title":"Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies","volume":"88","author":"Hartzell","year":"2008","journal-title":"Physiol. Rev."},{"issue":"Pt 12","key":"10.1016\/j.exer.2022.108961_bib34","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1099\/vir.0.046672-0","article-title":"Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer","volume":"93","author":"Hastie","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.exer.2022.108961_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.exer.2022.108961_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ng1394","article-title":"Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy","volume":"36","author":"Janecke","year":"2004","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40778-015-0014-4","article-title":"Regenerating retinal pigment epithelial cells to cure blindness: a road towards personalized artificial tissue","volume":"1","author":"Jha","year":"2015","journal-title":"Curr. Stem Cell. Rep."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1167\/iovs.16-19778","article-title":"Evaluation of the surgical device and procedure for extracellular matrix\u2013scaffold\u2013supported human iPSC\u2013derived retinal pigment epithelium cell sheet transplantation","volume":"58","author":"Kamao","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"19","key":"10.1016\/j.exer.2022.108961_bib39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/gt.2008.78","article-title":"Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy","volume":"15","author":"Kong","year":"2008","journal-title":"Gene Ther."},{"issue":"9","key":"10.1016\/j.exer.2022.108961_bib40","first-page":"2987","article-title":"Safety and activity of a single, intravitreal injection of human retinal progenitor cells (jCell) for treatment of retinitis pigmentosa (RP)","volume":"59","author":"Kuppermann","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.108961_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.09.012","article-title":"Choroideremia gene therapy phase 2 clinical trial: 24-month results","volume":"197","author":"Lam","year":"2019","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","article-title":"Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis","volume":"26","author":"Le Meur","year":"2018","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tjo.2015.06.002","article-title":"Rod metabolic demand drives progression in retinopathies","volume":"5","author":"Lin","year":"2015","journal-title":"Taiwan J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-018-0053-y","article-title":"Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration","volume":"4","author":"Liu","year":"2018","journal-title":"Cell Discov."},{"issue":"8","key":"10.1016\/j.exer.2022.108961_bib45","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/gt.2013.3","article-title":"Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus","volume":"20","author":"Lopes","year":"2013","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib46","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017319","article-title":"Gene therapy for the retinal degeneration of Usher syndrome caused by mutations in MYO7A","volume":"5","author":"Lopes","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"17","key":"10.1016\/j.exer.2022.108961_bib47","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1089\/104303403322542301","article-title":"Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina","volume":"14","author":"Lotery","year":"2003","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/clo.2006.8.189","article-title":"Human embryonic stem cell\u2013derived cells rescue visual function in dystrophic RCS rats","volume":"8","author":"Lund","year":"2006","journal-title":"Clon Stem Cell"},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib49","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.02.105","article-title":"Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization","volume":"8","author":"Lv","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"421","key":"10.1016\/j.exer.2022.108961_bib50","article-title":"Human ESC\u2013derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration","volume":"9","author":"M'Barek","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2022.108961_bib51","first-page":"2706","article-title":"RDH12 retinopathy: novel mutations and phenotypic description","volume":"17","author":"Mackay","year":"2011","journal-title":"Mol. Vis."},{"issue":"21","key":"10.1016\/j.exer.2022.108961_bib52","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib53","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.2910320610","article-title":"A pigmentation\u2010associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum","volume":"32","author":"Mattes","year":"1983","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1097-198","article-title":"Mutation of the gene encoding cellular retinaldehyde\u2013binding protein in autosomal recessive retinitis pigmentosa","volume":"17","author":"Maw","year":"1997","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.exer.2022.108961_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trsl.2012.12.007","article-title":"Gene therapy for retinal disease","volume":"161","author":"McClements","year":"2013","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.exer.2022.108961_bib56","first-page":"611","article-title":"Focus: genome editing: adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes","volume":"90","author":"McClements","year":"2017","journal-title":"Yale J. Biol. Med."},{"issue":"11","key":"10.1016\/j.exer.2022.108961_bib57","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","article-title":"Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration","volume":"125","author":"Mehat","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2022.108961_bib58","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene transfer into mouse lyoma cells by electroporation in high electric fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO J."},{"key":"10.1016\/j.exer.2022.108961_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000357293","article-title":"Juvenile-onset macular degeneration and allied disorders","volume":"53","author":"North","year":"2014","journal-title":"Cell. Base. Ther. Retin. Degener. Dis."},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1566523211313020008","article-title":"Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases","volume":"13","author":"O Cramer","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.exer.2022.108961_bib61","article-title":"Regenerative medicine in the retina: from stem cells to cell replacement therapy","volume":"10","author":"Oswald","year":"2018","journal-title":"Ther. Adv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib62","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI200421686","article-title":"Rescue of retinal degeneration by intravitreally injected adult bone marrow\u2013derived lineage-negative hematopoietic stem cells","volume":"114","author":"Otani","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/ijms17030415","article-title":"Ocular stem cell research from basic science to clinical application: a report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium","volume":"17","author":"Ouyang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2022.108961_bib64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/TACG.S230720","article-title":"Voretigene neparvovec and gene therapy for leber's congenital amaurosis: review of evidence to date","volume":"13","author":"Padhy","year":"2020","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.exer.2022.108961_bib65","article-title":"Voretigene neparvovec: an emerging gene therapy for the treatment of inherited blindness","volume":"169","author":"Patel","year":"2018"},{"issue":"4","key":"10.1016\/j.exer.2022.108961_bib66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nbt.2157","article-title":"Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma","volume":"30","author":"Pulido","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2008.04.009","article-title":"Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium","volume":"146","author":"Radtke","year":"2008","journal-title":"Am. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.exer.2022.108961_bib68","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/mt.2010.167","article-title":"POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse","volume":"18","author":"Read","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2022.108961_bib69","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/mtm.2016.10","article-title":"Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies","volume":"3","author":"Riera","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10097","key":"10.1016\/j.exer.2022.108961_bib70","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2022.108961_bib71","series-title":"RPE Visual Cycle and Biochemical Phenotypes of Mutant Mouse Models. Mouse Retinal Phenotyping","first-page":"89","author":"Sahu","year":"2018"},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-5-182","article-title":"Enhanced generation of retinal progenitor cells from human retinal pigment epithelial cells induced by amniotic fluid","volume":"5","author":"Sanie-Jahromi","year":"2012","journal-title":"BMC Res. Notes"},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib73","first-page":"65","article-title":"The role of retinal pigment epithelium in the pathogenesis and treatment of age related macular degeneration","volume":"9","author":"Sanie-Jahromi","year":"2021","journal-title":"J. Infertil. Reprod. Biol."},{"key":"10.1016\/j.exer.2022.108961_bib74","doi-asserted-by":"crossref","first-page":"108528","DOI":"10.1016\/j.exer.2021.108528","article-title":"Effects of the secretome of human Wharton's jelly mesenchymal stem cells on the proliferation and apoptosis gene expression of the retinal pigmented epithelium","author":"Sanie-Jahromi","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.exer.2022.108961_bib75","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","article-title":"Risks associated with lentiviral vector exposures and prevention strategies","volume":"58","author":"Schlimgen","year":"2016","journal-title":"J. Occup. Environ. Med."},{"issue":"9967","key":"10.1016\/j.exer.2022.108961_bib76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.exer.2022.108961_bib77","article-title":"Subretinal transplantation of embryonic stem cell\u2013derived retinal pigment epithelium for the treatment of macular degeneration: an assessment at 4 years","volume":"57","author":"Schwartz","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.108961_bib78","series-title":"First AAV Gene Therapy Poised for Landmark Approval","author":"Smalley","year":"2017"},{"issue":"7","key":"10.1016\/j.exer.2022.108961_bib79","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib80","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ajo.2007.08.022","article-title":"Leber congenital amaurosis\u2013a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture","volume":"144","author":"Stone","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2022.108961_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/gt.2009.104","article-title":"Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations","volume":"17","author":"Sun","year":"2010","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib82","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000508383","article-title":"Clinical trials in metastatic uveal melanoma: current status","volume":"6","author":"Sussman","year":"2020","journal-title":"Ocular Oncol. Pathol."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib83","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ophtha.2012.11.048","article-title":"Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2","volume":"120","author":"Testa","year":"2013","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1016\/j.exer.2022.108961_bib84","first-page":"1916","article-title":"AAV-mediated expression of human Rdh12 in mouse Retina","volume":"53","author":"Thompson","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.108961_bib85","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pharmtox.47.120505.105225","article-title":"Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents","volume":"47","author":"Travis","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.exer.2022.108961_bib86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/genes10040289","article-title":"In vitro gene delivery in retinal pigment epithelium cells by plasmid DNA-wrapped gold nanoparticles","volume":"10","author":"Trigueros","year":"2019","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1242\/dmm.017913","article-title":"Biology and therapy of inherited retinal degenerative disease: insights from mouse models","volume":"8","author":"Veleri","year":"2015","journal-title":"Dis. Model. Mech."},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib89","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1525-0016(03)00098-4","article-title":"Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery","volume":"7","author":"Weber","year":"2003","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.exer.2022.108961_bib90","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ophtha.2016.03.003","article-title":"Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood\u2013onset retinal dystrophy","volume":"123","author":"Weleber","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2022.108961_bib91","first-page":"2286","article-title":"Early findings in a Phase I\/IIa clinical program for Usher syndrome 1B (USH1B; MIM# 276900)","volume":"56","author":"Weleber","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.108961_bib92","series-title":"Promoters, Enhancers, and Inducible Elements for Gene Therapy. Gene Therapeutics","first-page":"60","author":"Whalen","year":"1994"},{"issue":"2","key":"10.1016\/j.exer.2022.108961_bib93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00424-010-0821-5","article-title":"Bestrophins and retinopathies","volume":"460","author":"Xiao","year":"2010","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"issue":"9","key":"10.1016\/j.exer.2022.108961_bib94","first-page":"2468","article-title":"Human retinal progenitor cells (hRPCs) protect age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from cellular damage","volume":"59","author":"Yu","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.108961_bib95","article-title":"Age-related macular degeneration (AMD) transmitochondrial cybrids protected from cellular damage and death by human retinal progenitor cells (hRPCs)","volume":"2021","author":"Yu","year":"2021","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.exer.2022.108961_bib96","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000099259","article-title":"Immunosuppressive properties of the pigmented epithelial cells and the subretinal space","volume":"92","author":"Zamiri","year":"2007","journal-title":"Immune Response Eye"},{"issue":"6","key":"10.1016\/j.exer.2022.108961_bib97","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/hmg\/ddp583","article-title":"Suppression of Ca 2+ signaling in a mouse model of Best disease","volume":"19","author":"Zhang","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.exer.2022.108961_bib98","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14712598.2015.1006192","article-title":"Personalized therapeutic strategies for patients with retinitis pigmentosa","volume":"15","author":"Zheng","year":"2015","journal-title":"Expet Opin. Biol. Ther."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483522000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483522000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:16:43Z","timestamp":1757999803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483522000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":98,"alternative-id":["S0014483522000422"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2022.108961","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RPE based gene and cell therapy for inherited retinal diseases: A review","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2022.108961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108961"}}